Nonalcoholic fatty liver disease

Leon A. Adams, Paul Angulo, Keith Lindor

Research output: Contribution to journalArticle

383 Citations (Scopus)

Abstract

NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and hepatocellular carcinoma. Current treatment recommendations are limited to weight loss and exercise, although several promising medications are on the horizon. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.

Original languageEnglish (US)
Pages (from-to)899-905
Number of pages7
JournalCMAJ
Volume172
Issue number7
DOIs
StatePublished - Mar 29 2005
Externally publishedYes

Fingerprint

Western World
Liver
Liver Failure
Insulin Resistance
Weight Loss
Hepatocellular Carcinoma
Fibrosis
Enzymes
Non-alcoholic Fatty Liver Disease
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nonalcoholic fatty liver disease. / Adams, Leon A.; Angulo, Paul; Lindor, Keith.

In: CMAJ, Vol. 172, No. 7, 29.03.2005, p. 899-905.

Research output: Contribution to journalArticle

Adams, LA, Angulo, P & Lindor, K 2005, 'Nonalcoholic fatty liver disease', CMAJ, vol. 172, no. 7, pp. 899-905. https://doi.org/10.1503/cmaj.045232
Adams, Leon A. ; Angulo, Paul ; Lindor, Keith. / Nonalcoholic fatty liver disease. In: CMAJ. 2005 ; Vol. 172, No. 7. pp. 899-905.
@article{8d6dede62468472b871249723584dafc,
title = "Nonalcoholic fatty liver disease",
abstract = "NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and hepatocellular carcinoma. Current treatment recommendations are limited to weight loss and exercise, although several promising medications are on the horizon. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.",
author = "Adams, {Leon A.} and Paul Angulo and Keith Lindor",
year = "2005",
month = "3",
day = "29",
doi = "10.1503/cmaj.045232",
language = "English (US)",
volume = "172",
pages = "899--905",
journal = "Canadian Medical Association Journal",
issn = "0008-4409",
publisher = "Canadian Medical Association",
number = "7",

}

TY - JOUR

T1 - Nonalcoholic fatty liver disease

AU - Adams, Leon A.

AU - Angulo, Paul

AU - Lindor, Keith

PY - 2005/3/29

Y1 - 2005/3/29

N2 - NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and hepatocellular carcinoma. Current treatment recommendations are limited to weight loss and exercise, although several promising medications are on the horizon. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.

AB - NONALCOHOLIC FATTY LIVER DISEASE is emerging as the most common chronic liver condition in the Western world. It is associated with insulin resistance and frequently occurs with features of the metabolic syndrome. Disease presentation ranges from asymptomatic elevated liver enzyme levels to cirrhosis with complications of liver failure and hepatocellular carcinoma. Current treatment recommendations are limited to weight loss and exercise, although several promising medications are on the horizon. In this article we discuss the etiology, pathogenesis and diagnosis of nonalcoholic fatty liver disease as well as approaches to its management.

UR - http://www.scopus.com/inward/record.url?scp=17444417085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17444417085&partnerID=8YFLogxK

U2 - 10.1503/cmaj.045232

DO - 10.1503/cmaj.045232

M3 - Article

C2 - 15795412

AN - SCOPUS:17444417085

VL - 172

SP - 899

EP - 905

JO - Canadian Medical Association Journal

JF - Canadian Medical Association Journal

SN - 0008-4409

IS - 7

ER -